ADIPOQ and chronic kidney disease: In 2019, our further progress showed that the urinary adiponectin levels increased with an increase in the chronic kidney disease risk and that urinary adiponectin mainly formed a medium-molecular weight multimer in DM patients, whereas it formed only a low-molecular-weight multimer in healthy subjects [11].